BioCentury
ARTICLE | Politics & Policy

Pharma group calls for medicines exemptions after U.K. Brexit vote

January 15, 2019 9:55 PM UTC

Biopharma groups reiterated that a no-deal Brexit constitutes a real threat to patient safety and public health after the House of Commons' decisive vote against the Withdrawal Agreement for the U.K.'s exit from the EU. The European Federation of Pharmaceutical Industries and Associations (EFPIA) went even further, calling on negotiators from both sides to implement temporary measures that would prioritize the movement of medicines in the event of a no-deal Brexit.

The Withdrawal Agreement was voted down 432-202...